756 related articles for article (PubMed ID: 9658403)
21. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin.
Ning YM; Sánchez ER
J Biol Chem; 1993 Mar; 268(9):6073-6. PubMed ID: 7681058
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin.
Silverstein AM; Galigniana MD; Chen MS; Owens-Grillo JK; Chinkers M; Pratt WB
J Biol Chem; 1997 Jun; 272(26):16224-30. PubMed ID: 9195923
[TBL] [Abstract][Full Text] [Related]
23. Steroid receptor interactions with heat shock protein and immunophilin chaperones.
Pratt WB; Toft DO
Endocr Rev; 1997 Jun; 18(3):306-60. PubMed ID: 9183567
[TBL] [Abstract][Full Text] [Related]
24. Direct interaction of the Krüppel-like family (KLF) member, BTEB1, and PR mediates progesterone-responsive gene expression in endometrial epithelial cells.
Zhang D; Zhang XL; Michel FJ; Blum JL; Simmen FA; Simmen RC
Endocrinology; 2002 Jan; 143(1):62-73. PubMed ID: 11751593
[TBL] [Abstract][Full Text] [Related]
25. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
26. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
[TBL] [Abstract][Full Text] [Related]
27. The role of DnaJ-like proteins in glucocorticoid receptor.hsp90 heterocomplex assembly by the reconstituted hsp90.p60.hsp70 foldosome complex.
Dittmar KD; Banach M; Galigniana MD; Pratt WB
J Biol Chem; 1998 Mar; 273(13):7358-66. PubMed ID: 9516432
[TBL] [Abstract][Full Text] [Related]
28. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51.
Reynolds PD; Ruan Y; Smith DF; Scammell JG
J Clin Endocrinol Metab; 1999 Feb; 84(2):663-9. PubMed ID: 10022435
[TBL] [Abstract][Full Text] [Related]
30. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
31. Stabilization in vitro of the untransformed glucocorticoid receptor complex of S49 lymphocytes by the immunophilin ligand FK506.
Ning YM; Sanchez ER
J Steroid Biochem Mol Biol; 1995 Feb; 52(2):187-94. PubMed ID: 7532989
[TBL] [Abstract][Full Text] [Related]
32. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
Selkirk JK; Merrick BA; Stackhouse BL; He C
Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
[TBL] [Abstract][Full Text] [Related]
33. Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells--a possible interaction with psychotropic drugs.
Basta-Kaim A; Budziszewska B; Jaworska-Feil L; Leśkiewicz M; Tetich M; Otczyk M; Kubera M; Lasoń W
Eur Neuropsychopharmacol; 2007 Jan; 17(1):37-45. PubMed ID: 16581232
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
35. FK506 binding to the 56-kilodalton immunophilin (Hsp56) in the glucocorticoid receptor heterocomplex has no effect on receptor folding or function.
Hutchison KA; Scherrer LC; Czar MJ; Ning Y; Sanchez ER; Leach KL; Deibel MR; Pratt WB
Biochemistry; 1993 Apr; 32(15):3953-7. PubMed ID: 7682438
[TBL] [Abstract][Full Text] [Related]
36. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.
Narayanan R; Edwards DP; Weigel NL
Mol Cell Biol; 2005 Apr; 25(8):2885-98. PubMed ID: 15798179
[TBL] [Abstract][Full Text] [Related]
37. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
Zhang X; Jeyakumar M; Bagchi MK
J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
[TBL] [Abstract][Full Text] [Related]
38. Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines.
Read LD; Snider CE; Miller JS; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1988 Mar; 2(3):263-71. PubMed ID: 3398853
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor.
Nair SC; Rimerman RA; Toran EJ; Chen S; Prapapanich V; Butts RN; Smith DF
Mol Cell Biol; 1997 Feb; 17(2):594-603. PubMed ID: 9001212
[TBL] [Abstract][Full Text] [Related]
40. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
